Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Top OTC Stories 2013: Switch, Consumer Business Divestment Plans

This article was originally published in The Tan Sheet

Executive Summary

The most-read OTC sector stories in “The Tan Sheet” during 2013 include Sanofi’s switch of Nasacort AQ 24HR, an interview with the former director of FDA’s Division of Nonprescription Clinical Evaluation, and Merck and Novartis each pondering the sale of its consumer health unit.


Related Content

“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
Sanofi Sues FDA To Stop Publication Of Nasacort Labeling Before Launch
Sanofi’s Nasacort First-In-Class Switch Receives FDA Approval
Novartis Seems Close to Consumer Health Sale – Analyst
Interview: Leonard-Segal On OTC Switch Past, Present and Future
Plan B One-Step OTC Proposal Leaves Plaintiffs, Judge Korman Wary
Novartis Divests Non-Core OTCs, Realigns Consumer Supply Chain
Oxytrol For Women Gets OTC Green Light As Rare First-In-Class Switch


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts